mitoxantrone has been researched along with Splenic Rupture in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Splenic Rupture: Rupture of the SPLEEN due to trauma or disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deenik, W | 1 |
| Beverloo, HB | 1 |
| van der Poel-van de Luytgaarde, SC | 1 |
| Wattel, MM | 1 |
| van Esser, JW | 1 |
| Valk, PJ | 1 |
| Cornelissen, JJ | 1 |
1 other study available for mitoxantrone and Splenic Rupture
| Article | Year |
|---|---|
Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Cytarabine; | 2009 |